(FY)Dec 31, 2020 | |
---|---|
Operating Cash Flow (Indirect Method) | |
Cash flow from continuing operating activities | 188.14M |
Net income from continuing operations | --100.72M |
Operating gains losses | --293K |
Depreciation and amortization | --54.86M |
Other non cash items | --3.63M |
Change In working capital | --24.15M |
-Change in receivables | ---32.45M |
-Change in prepaid assets | ---3.02M |
-Change in payables and accrued expense | --59.62M |
Cash from discontinued investing activities | |
Operating cash flow | --188.14M |
Investing cash flow | |
Cash flow from continuing investing activities | -29.32M |
Net PPE purchase and sale | ---26.16M |
Net business purchase and sale | ---3.17M |
Cash from discontinued investing activities | |
Investing cash flow | ---29.32M |
Financing cash flow | |
Cash flow from continuing financing activities | -111.17M |
Net issuance payments of debt | ---6.72M |
Net common stock issuance | --0 |
Cash dividends paid | ---104.45M |
Cash from discontinued financing activities | |
Financing cash flow | ---111.17M |
Net cash flow | |
Beginning cash position | --77.73M |
Current changes in cash | --47.65M |
End cash Position | --125.38M |
Free cash flow | --161.98M |
Currency Unit | USD |
Audit Opinions | Unqualified Opinion |
No Data